Peretinoin

N/A

Report date: 2022/10/19 16:54:02
NME

Base Information

Drug NamePeretinoin
Drug Alias NamePolyprenoic acid开环维A酸Acyclic retinoid培维A酸peretinoinum +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinoid X receptor agonistsRetinoic acid receptors agonists
TargetsRetinoid X receptorRetinoic acid receptors
Therapy Area/IndicationsLiver NeoplasmsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesEisai Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKowa Company, Ltd., Fuji FactoryKowa Dental Health Co LtdEps International (China) Co Ltd
Inactive CompaniesKowa Company Ltd
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsLiver Neoplasms

Other Information

ATC CodeN/A
Related LinksKEGG